logo
  • 首页
  • 学术期刊
  • 论文检测
  • AIGC检测
  • 热点
  • 更多
    • 数据

VedolizumabLack of efficacy following off-label use: case report

被引:0
|
作者:
机构:
来源:
Reactions Weekly | 2023年 / 1938卷 / 1期
关键词:
D O I:
10.1007/s40278-023-31391-8
中图分类号:
学科分类号:
摘要:
引用
收藏
页码:1250 / 1250
相关论文
共 50 条
  • [21] EribulinLack of efficacy following off-label use: case report
    Reactions Weekly, 2022, 1921 (1) : 135 - 135
  • [22] ImiquimodLack of efficacy following off-label use: case report
    Reactions Weekly, 2022, 1920 (1) : 254 - 254
  • [23] IbrutinibLack of efficacy following off-label use: case report
    Reactions Weekly, 2025, 2042 (1) : 209 - 209
  • [24] InterferonLack of efficacy following off-label use: case report
    Reactions Weekly, 2024, 2025 (1) : 231 - 231
  • [25] TocilizumabLack of efficacy following off-label use: case report
    Reactions Weekly, 2022, 1887 (1) : 643 - 643
  • [26] DexamethasoneLack of efficacy following off-label use: case report
    Reactions Weekly, 2022, 1936 (1) : 195 - 195
  • [27] ApixabanLack of efficacy following off-label use: case report
    Reactions Weekly, 2022, 1935 (1) : 89 - 89
  • [28] CabazitaxelLack of efficacy following off-label use: case report
    Reactions Weekly, 2023, 1980 (1) : 102 - 102
  • [29] OxcarbazepineLack of efficacy following off-label use: case report
    Reactions Weekly, 2022, 1905 (1) : 409 - 409
  • [30] Catequentinib/sintilimabLack of efficacy following off-label use: case report
    Reactions Weekly, 2023, 1958 (1) : 135 - 135
← 12345 →